SMTL ID : 1uho.1

Crystal structure of Human Phosphodiesterase 5 complexed with Vardenafil(Levitra)

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.50 Å

Oligo State

monomer

Ligands

1 x ZN: ZINC ION(Non-covalent)

ZN.1: 5 residues within 4Å: Chain A: H.81, H.117, D.118, D.228 Ligands: MG.2 5 PLIP interactions: 4 interactions with chain A, 1 Ligand-Water interactions Metal complexes: A:H.81, A:H.117, A:D.118, A:D.228, H2O.2

1 x MG: MAGNESIUM ION(Non-covalent)

MG.2: 6 residues within 4Å: Chain A: H.117, D.118, E.146, H.149, T.187 Ligands: ZN.1 3 PLIP interactions: 1 interactions with chain A, 2 Ligand-Water interactions Metal complexes: A:D.118, H2O.2, H2O.4

1 x VDN: 2-{2-ETHOXY-5-[(4-ETHYLPIPERAZIN-1-YL)SULFONYL]PHENYL}-5-METHYL-7-PROPYLIMIDAZO[5,1-F][1,2,4]TRIAZIN-4(1H)-ONE(Non-covalent)

VDN.3: 11 residues within 4Å: Chain A: Y.76, H.77, Y.128, A.243, A.247, F.250, L.268, M.280, Q.281, G.283, F.284 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:A.247, A:F.250, A:L.268, A:M.280, A:F.284 Hydrogen bonds: A:Y.76, A:Q.281 pi-Stacking: A:F.284

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Sung, B.-J. et al., Structure of the catalytic domain of human phosphodiesterase 5 with bound drug molecules. Nature (2003)

Release Date

2004-07-09

Peptides

cGMP-specific 3',5'-cyclic phosphodiesterase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

cGMP-specific 3',5'-cyclic phosphodiesterase

Related Entries With Identical Sequence